- Home
- JPM vs LLY Comparison
JPM vs LLY Comparison
Compare JPM & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JPM
- LLY
- Stock Information
- Founded
- JPM 1799
- LLY 1876
- Country
- JPM United States
- LLY United States
- Employees
- JPM N/A
- LLY N/A
- Industry
- JPM Major Banks
- LLY Biotechnology: Pharmaceutical Preparations
- Sector
- JPM Finance
- LLY Health Care
- Exchange
- JPM Nasdaq
- LLY Nasdaq
- Market Cap
- JPM 687.5B
- LLY 652.7B
- IPO Year
- JPM N/A
- LLY N/A
- Fundamental
- Price
- JPM $231.96
- LLY $839.96
- Analyst Decision
- JPM Buy
- LLY Strong Buy
- Analyst Count
- JPM 15
- LLY 17
- Target Price
- JPM $257.36
- LLY $1,020.35
- AVG Volume (30 Days)
- JPM 14.6M
- LLY 4.0M
- Earning Date
- JPM 04-11-2025
- LLY 05-01-2025
- Dividend Yield
- JPM 2.18%
- LLY 0.71%
- EPS Growth
- JPM 23.06
- LLY 101.90
- EPS
- JPM 20.39
- LLY 11.71
- Revenue
- JPM $168,730,000,000.00
- LLY $45,042,700,000.00
- Revenue This Year
- JPM $6.38
- LLY $33.50
- Revenue Next Year
- JPM $3.25
- LLY $19.40
- P/E Ratio
- JPM $11.38
- LLY $71.73
- Revenue Growth
- JPM 12.74
- LLY 32.00
- 52 Week Low
- JPM $179.97
- LLY $677.09
- 52 Week High
- JPM $280.25
- LLY $972.53
- Technical
- Relative Strength Index (RSI)
- JPM 46.67
- LLY 57.93
- Support Level
- JPM $227.93
- LLY $730.34
- Resistance Level
- JPM $239.78
- LLY $765.31
- Average True Range (ATR)
- JPM 10.14
- LLY 36.74
- MACD
- JPM 0.83
- LLY 4.69
- Stochastic Oscillator
- JPM 66.09
- LLY 90.03
About JPM JP Morgan Chase & Co.
JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with nearly $4.1 trillion in assets. It is organized into four major segments--consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates, and is subject to regulation, in multiple countries.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.